Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate) Images

Generic Name: sodium oxybate

This medication has been identified as Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate). It is supplied by Jazz Pharmaceuticals plc.

Xyrem is used in the treatment of Cataplexy; Idiopathic Hypersomnia; Narcolepsy and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. There is no proven risk in humans during pregnancy. Xyrem 0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images of medication

Xyrem

Generic Name

sodium oxybate

Strength

0.5 g per mL (0.5 g/mL of sodium oxybate equivalent to 0.413 g/mL of oxybate)

Availability

Prescription only

Drug Class

Miscellaneous anxiolytics, sedatives and hypnotics

Pregnancy Category

B - No proven risk in humans

CSA Schedule

3 - Moderate abuse potential

Labeler / Supplier

Jazz Pharmaceuticals plc

National Drug Code (NDC)

68727-0100

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer